Venous thromboembolism after joint arthroplasty: where do we stand with aspirin?
Open Access
- 1 November 2026
- journal article
- Published by Bioscientifica in EFORT Open Reviews
- Vol. 11 (11) , 1228-1235
Abstract
Venous thromboembolism prophylaxis after total joint arthroplasty remains heterogeneous, particularly regarding the role of aspirin within modern fast-track pathways. Although aspirin is widely used in North American arthroplasty practice, European guidelines remain more conservative and often provide limited or non-operational recommendations for its use after total hip and knee arthroplasty. Contemporary evidence supports aspirin as a viable prophylactic option in selected patients, with potential advantages related to its safety profile, cost, ease of administration and reduced treatment burden. The clinical role of aspirin should be interpreted within a risk-stratified framework that accounts for thromboembolic risk, bleeding risk, surgical complexity, early mobilization and duration of prophylaxis. Available evidence, including recent randomized data, supports aspirin-based prophylaxis in appropriately selected patients, both as part of sequential strategies and, increasingly, as monotherapy within contemporary fast-track pathways. This scoping review synthesizes current guideline-level evidence and contemporary clinical data to clarify practical considerations for agent selection, dosing, duration and aspirin-based prophylaxis after total joint arthroplasty.Keywords
This publication has 51 references indexed in Scilit:
- The efficacy of aspirin versus low‐molecular‐weight heparin for venous thromboembolism prophylaxis after knee and hip arthroplasty: A systematic review and meta‐analysis of randomized controlled trialsKnee Surgery, Sports Traumatology, Arthroscopy, 2024
- Aspirin is a safe and effective thromboembolic prophylaxis after total knee arthroplasty: a systematic review and meta‐analysisKnee Surgery, Sports Traumatology, Arthroscopy, 2023
- Non-Inferiority of Aspirin for Venous Thromboembolism Prophylaxis After Hip Arthroplasty in a Statewide RegistryThe Journal of Arthroplasty, 2021
- Persistent Wound Drainage among Total Joint Arthroplasty Patients Receiving Aspirin vs CoumadinThe Journal of Arthroplasty, 2020
- A Narrative Review of Aspirin Resistance in VTE Prophylaxis for Orthopaedic SurgeryDrugs, 2020
- Is Aspirin as Effective as the Newer Direct Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Total Hip and Knee Arthroplasty? An Analysis From the National Joint Registry for England, Wales, Northern Ireland, and the Isle of ManThe Journal of Arthroplasty, 2020
- Have Venous Thromboembolism Rates Decreased in Total Hip and Knee Arthroplasty?The Journal of Arthroplasty, 2020
- The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United StatesThe Journal of Arthroplasty, 2017
- Complications Related to Therapeutic Anticoagulation in Total Hip ArthroplastyThe Journal of Arthroplasty, 2013
- Does “Excessive” Anticoagulation Predispose to Periprosthetic Infection?The Journal of Arthroplasty, 2007